ID_events | cancer | TypeID | ImmuneCell | P | R | CorrelationPlot |
chr9:128227065-128231524:+ | BRCA | EER | Monocytes | 1.5079e-02 | 0.2936 |  |
ENSG00000106976.17,DNM1 | BRCA | EAG | Monocytes | 3.4605e-02 | 0.2494 |  |
chr9:128227065-128231524:+ | ESCA | EER | Neutrophils | 1.4206e-02 | 0.2522 |  |
ENSG00000106976.17,DNM1 | ESCA | EAG | Neutrophils | 1.4630e-02 | 0.2511 |  |
ENSG00000106976.17,DNM1 | GBM | EAG | B_cells_naive | 2.8534e-02 | -0.2582 |  |
chr9:128227065-128231524:+ | KIRC | EER | Dendritic_cells_activated | 3.8681e-02 | 0.2460 |  |
ENSG00000106976.17,DNM1 | KIRC | EAG | Dendritic_cells_activated | 3.8355e-02 | 0.2464 |  |
chr9:128227065-128231524:+ | KIRP | EER | Macrophages_M0 | 3.7770e-03 | 0.2230 |  |
ENSG00000106976.17,DNM1 | KIRP | EAG | Macrophages_M0 | 3.5883e-03 | 0.2242 |  |
chr9:128227065-128231524:+ | LGG | EER | Mast_cells_activated | 1.1493e-02 | 0.2079 |  |
ENSG00000106976.17,DNM1 | LGG | EAG | T_cells_CD4_naive | 1.3111e-02 | 0.2002 |  |
ENSG00000106976.17,DNM1 | LUAD | EAG | Eosinophils | 9.6022e-03 | 0.5639 |  |
chr9:128227065-128231524:+ | LUSC | EER | NK_cells_resting | 3.0395e-02 | 0.3664 |  |
ENSG00000106976.17,DNM1 | LUSC | EAG | NK_cells_resting | 3.0823e-02 | 0.3604 |  |
chr9:128227065-128231524:+ | SARC | EER | Plasma_cells | 2.1611e-02 | 0.3038 |  |
ENSG00000106976.17,DNM1 | SARC | EAG | Plasma_cells | 1.5420e-02 | 0.3167 |  |
chr9:128227065-128231524:+ | SKCM | EER | T_cells_regulatory_(Tregs) | 2.7543e-02 | 0.4023 | .chr9_128227065-128231524_+.png) |
ENSG00000106976.17,DNM1 | SKCM | EAG | T_cells_regulatory_(Tregs) | 2.7543e-02 | 0.4023 | .ENSG00000106976.17,DNM1.png) |
chr9:128227065-128231524:+ | STAD | EER | Monocytes | 3.5573e-03 | 0.2465 |  |
ENSG00000106976.17,DNM1 | STAD | EAG | Monocytes | 1.9988e-03 | 0.2609 |  |
chr9:128227065-128231524:+ | TGCT | EER | T_cells_regulatory_(Tregs) | 2.0679e-02 | 0.5011 | .chr9_128227065-128231524_+.png) |
ENSG00000106976.17,DNM1 | TGCT | EAG | Monocytes | 1.9800e-02 | 0.4928 |  |
ID_events | cancer | HallmarkType | Type | P | R | CorrelationPlot |
chr9:128227065-128231524:+ | BRCA | GSVA_HALLMARK_FATTY_ACID_METABOLISM | EER | 3.7177e-04 | 0.4193 |  |
ENSG00000106976.17,DNM1 | BRCA | GSVA_HALLMARK_FATTY_ACID_METABOLISM | EAG | 3.8801e-05 | 0.4649 |  |
ENSG00000106976.17,DNM1 | ESCA | GSVA_HALLMARK_ADIPOGENESIS | EAG | 2.6921e-03 | 0.3061 |  |
chr9:128227065-128231524:+ | ESCA | GSVA_HALLMARK_ADIPOGENESIS | EER | 3.7797e-03 | 0.2959 |  |
chr9:128227065-128231524:+ | GBM | GSVA_HALLMARK_HEME_METABOLISM | EER | 4.9106e-03 | 0.3280 |  |
ENSG00000106976.17,DNM1 | GBM | GSVA_HALLMARK_HEME_METABOLISM | EAG | 8.7614e-03 | 0.3068 |  |
chr9:128227065-128231524:+ | KIRC | GSVA_HALLMARK_KRAS_SIGNALING_DN | EER | 4.4568e-04 | 0.4058 |  |
ENSG00000106976.17,DNM1 | KIRC | GSVA_HALLMARK_KRAS_SIGNALING_DN | EAG | 4.6199e-04 | 0.4048 |  |
ENSG00000106976.17,DNM1 | KIRP | GSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY | EAG | 2.2158e-08 | 0.4162 |  |
chr9:128227065-128231524:+ | KIRP | GSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY | EER | 1.7982e-08 | 0.4186 |  |
chr9:128227065-128231524:+ | LAML | GSVA_HALLMARK_G2M_CHECKPOINT | EER | 3.5892e-02 | 0.2266 |  |
ENSG00000106976.17,DNM1 | LAML | GSVA_HALLMARK_G2M_CHECKPOINT | EAG | 3.6558e-02 | 0.2258 |  |
chr9:128227065-128231524:+ | LGG | GSVA_HALLMARK_G2M_CHECKPOINT | EER | 3.6616e-02 | -0.1726 |  |
ENSG00000106976.17,DNM1 | LUAD | GSVA_HALLMARK_ESTROGEN_RESPONSE_EARLY | EAG | 2.8684e-02 | -0.4890 |  |
chr9:128227065-128231524:+ | OV | GSVA_HALLMARK_UV_RESPONSE_UP | EER | 1.0447e-04 | 0.3569 |  |
ENSG00000106976.17,DNM1 | OV | GSVA_HALLMARK_UV_RESPONSE_UP | EAG | 1.0383e-04 | 0.3570 |  |
ENSG00000106976.17,DNM1 | SARC | GSVA_HALLMARK_PANCREAS_BETA_CELLS | EAG | 3.3609e-02 | 0.2795 |  |
chr9:128227065-128231524:+ | SARC | GSVA_HALLMARK_PANCREAS_BETA_CELLS | EER | 3.5208e-02 | 0.2796 |  |
ENSG00000106976.17,DNM1 | SKCM | GSVA_HALLMARK_APICAL_JUNCTION | EAG | 3.5066e-04 | 0.6094 |  |
chr9:128227065-128231524:+ | SKCM | GSVA_HALLMARK_APICAL_JUNCTION | EER | 3.5066e-04 | 0.6094 |  |
ENSG00000106976.17,DNM1 | STAD | GSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATION | EAG | 3.3129e-02 | 0.1815 |  |
chr9:128227065-128231524:+ | STAD | GSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATION | EER | 3.1415e-02 | 0.1833 |  |
ENSG00000106976.17,DNM1 | TGCT | GSVA_HALLMARK_DNA_REPAIR | EAG | 3.2532e-02 | 0.4569 |  |
ID_events | cancer | Drug | Type | P | R | CorrelationPlot |
chr9:128227065-128231524:+ | BRCA | Elesclomol | EER | 1.5766e-03 | -0.3760 |  |
ENSG00000106976.17,DNM1 | BRCA | Elesclomol | EAG | 2.1230e-03 | -0.3564 |  |
chr9:128227065-128231524:+ | CESC | Dasatinib | EER | 2.3466e-04 | -0.4727 |  |
ENSG00000106976.17,DNM1 | CESC | Dasatinib | EAG | 2.3473e-04 | -0.4727 |  |
ENSG00000106976.17,DNM1 | ESCA | Bexarotene | EAG | 3.6137e-02 | -0.2165 |  |
chr9:128227065-128231524:+ | ESCA | Bexarotene | EER | 2.9955e-02 | -0.2240 |  |
chr9:128227065-128231524:+ | GBM | CEP.701 | EER | 6.2939e-05 | 0.4536 |  |
ENSG00000106976.17,DNM1 | GBM | CEP.701 | EAG | 1.5997e-04 | 0.4306 |  |
chr9:128227065-128231524:+ | KIRC | Bexarotene | EER | 2.2450e-04 | -0.4245 |  |
ENSG00000106976.17,DNM1 | KIRC | Bexarotene | EAG | 2.4413e-04 | -0.4223 |  |
ENSG00000106976.17,DNM1 | KIRP | MG.132 | EAG | 8.8231e-05 | -0.2996 |  |
chr9:128227065-128231524:+ | KIRP | MG.132 | EER | 6.1603e-05 | -0.3058 |  |
chr9:128227065-128231524:+ | LAML | AICAR | EER | 2.1152e-02 | -0.2483 |  |
ENSG00000106976.17,DNM1 | LAML | AICAR | EAG | 2.0952e-02 | -0.2487 |  |
chr9:128227065-128231524:+ | LGG | CMK | EER | 4.0999e-02 | 0.1688 |  |
ENSG00000106976.17,DNM1 | LUAD | Cisplatin | EAG | 9.3424e-03 | -0.5656 |  |
chr9:128227065-128231524:+ | LUSC | MG.132 | EER | 2.4162e-02 | -0.3860 |  |
chr9:128227065-128231524:+ | OV | CCT007093 | EER | 1.8821e-03 | 0.2893 |  |
ENSG00000106976.17,DNM1 | OV | CCT007093 | EAG | 1.8253e-03 | 0.2901 |  |
ENSG00000106976.17,DNM1 | PAAD | KU.55933 | EAG | 4.7111e-02 | 0.4008 |  |
ENSG00000106976.17,DNM1 | SARC | BIRB.0796 | EAG | 1.8691e-02 | -0.3079 |  |
chr9:128227065-128231524:+ | SARC | Metformin | EER | 1.5672e-02 | -0.3187 |  |
ENSG00000106976.17,DNM1 | SKCM | Gefitinib | EAG | 5.1790e-03 | -0.4973 |  |
chr9:128227065-128231524:+ | SKCM | Gefitinib | EER | 5.1790e-03 | -0.4973 |  |
chr9:128227065-128231524:+ | TGCT | Cisplatin | EER | 1.0250e-02 | -0.5472 |  |
ENSG00000106976.17,DNM1 | TGCT | Cisplatin | EAG | 3.9865e-03 | -0.5882 |  |